Management Team
IDT Biologika is a company of enduring strength, which we recognized with 100th-year anniversary celebrations in 2021. We are privileged to play a role in development and manufacture of the world’s leading vaccines, viral vectors, and therapeutics, which play an ongoing vital role in protecting people and improving quality of life for millions around the world. IDT Biologika has navigated 100 years and continues to bring value to customers as a result of our exceptional people.
Corporate Leadership Team
Dr. Ulrich Valley
Chief Executive Officer
Dr. Ulrich Valley has many years of experience in the pharmaceutical industry and has held various management positions with a focus on Technical Operations, Supply Chain and Development.
He holds a Ph.D. in Biotechnology from the University Of Braunschweig (Germany), where he also received his diploma.
Dr. Sally Choe
Chief Executive Officer
Dr. Sally Choe holds a Master’s and Ph.D. in Pharmaceutics from the University of Michigan, has worked for global pharmaceutical companies such as Pfizer, Bristol-Myers Squibb (BMS) and Parexel Regulatory Consulting firm. She has 12 years of tenure at the U.S. Food and Drug Administration (FDA), where she served as a Deputy Director in the Office of Translational Sciences (OTS) and as Super Office Director of the Office of Generic Drugs (OGD).
Dr. Christian Scheer
Senior Vice President Quality
Dr. Christian Scheer has extensive experience in quality management in the pharmaceutical industry. He studied Agriculture at the universities of Göttingen and Gießen, Germany, with a focus on molecular plant genetics, completing his studies at the TU Munich with a PhD in Biochemistry.
North American Operations
Dr. Manoj Menon
Managing Director
Dr. Manoj Menon has over 20 years of experience in the biopharma industry in biologics product development and commercial launches, establishment of global product supply chains, contract manufacturing, international technology transfers, and manufacturing facility validation. He holds a Ph.D. in Chemical Engineering from the University of Delaware, and Bachelors/Masters in Biochemical Engineering and Biotechnology from Indian Institute of Technology, New Delhi.
Ian Hart
Senior Director, Quality
Ian Hart is an accomplished Biopharma Manufacturing/CMC Leader with over 30 years of late stage development, commercial and clinical biologics manufacturing experience under US, Canadian and European cGMP regulations. He brings compliance and technical experience to provide the leadership to the site. He will be responsible for leading Quality Assurance and Quality Control functions. Ian holds an MBA from Schulich School of Business, Toronto, Canada, and a Chemical Engineering degree from the University of Waterloo, Waterloo, Canada.
Dr. Heidi Trusheim
Senior Director, Process Development
Dr. Heidi Trusheim is Senior Director, Process Development at IDT Biologika. As a scientist, Heidi has expertise in developing, overseeing, and validating processes to manufacture and commercialize novel biological products. She has over 20 years of experience in research and development, with 15 years in the biopharmaceutical industry. Heidi received her doctor’s degree and M.Sc. from the University of Osnabrück.